Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors

• Main Authors: Selin Genc (Author), Bahri Evren (Author), Onur Selcuk Yigit (Author), Ibrahim Sahin (Author), Ramazan Dayanan (Author), Aleksandra Klisic (Author), Ayse Erturk (Author), Filiz Mercantepe (Author)
• Format: Book
• Published: MDPI AG, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<b>Background/Objectives</b>: The antidiabetic effect of SGLT2 inhibitors (SGLT2-is) is based on their ability to increase glucose excretion through urine by inhibiting the kidney-resident SGLT2 protein. Euglycemic diabetic ketoacidosis (EuDKA) is an uncommon but potentially life-threate...